Options traders just made their loudest statement of the year on Blue Owl Capital. The put/call ratio hit 2.15 on August 13 — a 52-week high and 4.2 standard deviations above its 20-day mean of 1.36. That is not noise. That is the options market screaming caution into a 36% one-month rally.
A PCR of 2.15 means more than two puts are being bought for every call. The prior 20-day average was 1.36. The jump is abrupt — the ratio sat at 1.38 the day before. One session shifted the positioning from elevated to extreme. The 52-week low PCR is 0.53, which gives the full range: OWL's options market has swung from strongly bullish to its most defensive posture in a year, all while the stock is up more than a third in a month.
The previous note from August 5 flagged bears "holding ground" despite the post-earnings rally. That remains true. Short interest now stands at 17.8% of free float — roughly 118.6 million shares sold short. That is down from the ~19.5% level noted earlier this month, but it is still a substantial position. Bears who survived a 36% rally are not casual traders. They are convicted.
The borrow market has tightened meaningfully since that August 5 note. Availability has dropped from ~322% to 238% now. Cost to borrow has risen 79% in one week to 1.33%. Both moves point to rising demand for borrows — someone is adding short exposure even as the stock rallies. That is consistent with the options signal: new put buyers and new short sellers arriving simultaneously.
Multiple banks raised targets in early August following the August 6 earnings print. Goldman Sachs lifted to $10.50. BMO raised to $12.00. Both maintained neutral or outperform ratings. But the stock closed at $12.66 on August 13 — already above BMO's raised target. The consensus remains "hold." Analysts who raised targets after earnings are already underwater on those calls. The highest recent target in the data is $17.00 (Citizens), set in July with a market outperform rating.
That gap between the analyst consensus and where the stock is trading adds context to the options positioning. If the street is broadly neutral at prices already exceeded, put buyers may be expressing a view that the post-earnings re-rating has overshot.
The next earnings date is October 29. Between now and then, watch whether the PCR normalises back toward the 1.36 mean or holds elevated. A sustained PCR above 1.8 alongside continued CTB increases would suggest the bearish options activity is not a one-day artefact. Availability at 238% means the borrow market is comfortable — new shorts can still enter without friction — but the direction of travel over the past week has been toward tightening.
See the live data behind this article on ORTEX.
Open OWL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
